303 related articles for article (PubMed ID: 33122306)
1. Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy.
Liu CH; Chen Z; Chen K; Liao FT; Chung CE; Liu X; Lin YC; Keohavong P; Leikauf GD; Di YP
Cancer Res; 2021 Jan; 81(1):144-157. PubMed ID: 33122306
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis.
Narayanapillai SC; Han YH; Song JM; Kebede ME; Upadhyaya P; Kassie F
Carcinogenesis; 2020 Nov; 41(11):1518-1528. PubMed ID: 32602900
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Circ_0035266 Contributes to the Malignant Progression of Inflammation-Associated Malignant Transformed Cells Induced by Tobacco-Specific Carcinogen NNK.
Hua Q; Liu Y; Li M; Li X; Chen W; Diao Q; Ling Y; Jiang Y
Toxicol Sci; 2022 Sep; 189(2):203-215. PubMed ID: 35866630
[TBL] [Abstract][Full Text] [Related]
4. The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells.
Doukas SG; Vageli DP; Lazopoulos G; Spandidos DA; Sasaki CT; Tsatsakis A
Cells; 2020 Apr; 9(4):. PubMed ID: 32326378
[TBL] [Abstract][Full Text] [Related]
5. RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents.
Qian X; Khammanivong A; Song JM; Teferi F; Upadhyaya P; Dickerson E; Kassie F
Inflamm Res; 2015 May; 64(5):343-61. PubMed ID: 25795230
[TBL] [Abstract][Full Text] [Related]
6. Oral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J Mice.
Hu Q; Corral P; Narayanapillai SC; Leitzman P; Upadhyaya P; O'Sullivan MG; Hecht SS; Lu J; Xing C
Chem Res Toxicol; 2020 Jul; 33(7):1980-1988. PubMed ID: 32476407
[TBL] [Abstract][Full Text] [Related]
7. Lung carcinomas induced by NNK and LPS.
Di ME; Kahkonen B; Liu CH; Di YP
Methods Cell Biol; 2021; 163():175-185. PubMed ID: 33785164
[TBL] [Abstract][Full Text] [Related]
8. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
[TBL] [Abstract][Full Text] [Related]
9. Coexposure to Inhaled Aldehydes or Carbon Dioxide Enhances the Carcinogenic Properties of the Tobacco-Specific Nitrosamine 4-Methylnitrosamino-1-(3-pyridyl)-1-butanone in the A/J Mouse Lung.
Peterson LA; Oram MK; Flavin M; Seabloom D; Smith WE; O'Sullivan MG; Vevang KR; Upadhyaya P; Stornetta A; Floeder AC; Ho YY; Zhang L; Hecht SS; Balbo S; Wiedmann TS
Chem Res Toxicol; 2021 Mar; 34(3):723-732. PubMed ID: 33629582
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
11. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer.
Yin H; Pu N; Chen Q; Zhang J; Zhao G; Xu X; Wang D; Kuang T; Jin D; Lou W; Wu W
Cell Death Dis; 2021 Oct; 12(11):1033. PubMed ID: 34718325
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
Stabile LP; Kumar V; Gaither-Davis A; Huang EH; Vendetti FP; Devadassan P; Dacic S; Bao R; Steinman RA; Burns TF; Bakkenist CJ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351788
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor.
Njatcha C; Farooqui M; Almotlak AA; Siegfried JM
Cancer Prev Res (Phila); 2020 Sep; 13(9):735-746. PubMed ID: 32655003
[TBL] [Abstract][Full Text] [Related]
14. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
15. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP; Zhu AX; Wang Y
Front Immunol; 2020; 11():598877. PubMed ID: 33250900
[TBL] [Abstract][Full Text] [Related]
16. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
[TBL] [Abstract][Full Text] [Related]
17. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304
[TBL] [Abstract][Full Text] [Related]
18. B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy.
Zhao Y; Cao Y; Chen Y; Wu L; Hang H; Jiang C; Zhou X
Immunology; 2021 Nov; 164(3):507-523. PubMed ID: 34115389
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol.
Kassie F; Matise I; Negia M; Upadhyaya P; Hecht SS
Cancer Prev Res (Phila); 2008 Dec; 1(7):568-76. PubMed ID: 19139007
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.
Keohavong P; Kahkonen B; Kinchington E; Yin J; Jin J; Liu X; Siegfried JM; DI YP
Anticancer Res; 2011 Sep; 31(9):2877-82. PubMed ID: 21868532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
